Gene · 7337
Papers4,306
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 4,306
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chemically synthesized cinobufagin suppresses nasopharyngeal carcinoma metastasis by inducing ENKUR to stabilize p53 expression. | Cancer Lett | 2022 | 35114328 | PubTator, text mining | PubMed |
| RNF144A exerts tumor suppressor function in breast cancer through targeting YY1 for proteasomal degradation to downregulate GMFG expression. | Med Oncol | 2022 | 35103856 | PubTator, text mining | PubMed |
| First identification of two co-existing genome-wide significant sex quantitative trait loci (QTL) in red tilapia using integrative QTL mapping. | Zool Res | 2022 | 35084126 | PubTator, text mining | PubMed |
| All-trans retinoic acid inhibits HCV replication by downregulating core levels via E6AP-mediated proteasomal degradation. | Biochem Biophys Res Commun | 2022 | 35066375 | PubTator, text mining | PubMed |
| The polymorphism analysis and epitope predicted of Alphapapillomavirus 9 E6 in Sichuan, China. | Virol J | 2022 | 35057815 | PubTator, text mining | PubMed |
| Repositioning Fenofibrate to Reactivate p53 and Reprogram the Tumor-Immune Microenvironment in HPV+ Head and Neck Squamous Cell Carcinoma. | Cancers (Basel) | 2022 | 35053444 | PubTator, text mining | PubMed |
| Activation of E6AP/UBE3A-Mediated Protein Ubiquitination and Degradation Pathways by a Cyclic γ-AA Peptide. | J Med Chem | 2022 | 35045253 | PubTator, text mining | PubMed |
| Loss of the E6AP Ubiquitin Ligase Induces p53-Dependent Phosphorylation of Human Papillomavirus 18 E6 in Cells Derived from Cervical Cancer. | J Virol | 2022 | 35044207 | PubTator, text mining | PubMed |
| PROTAC targeted protein degraders: the past is prologue. | Nat Rev Drug Discov | 2022 | 35042991 | PubTator, text mining | PubMed |
| Myricetin: a Multifunctional Flavonol in Biomedicine. | Curr Pharmacol Rep | 2022 | 35036292 | PubTator, text mining | PubMed |
| An Update on Psychopharmacological Treatment of Autism Spectrum Disorder. | Neurotherapeutics | 2022 | 35029811 | PubTator, text mining | PubMed |
| HBXIP induces anoikis resistance by forming a reciprocal feedback loop with Nrf2 to maintain redox homeostasis and stabilize Prdx1 in breast cancer. | NPJ Breast Cancer | 2022 | 35027562 | PubTator, text mining | PubMed |
| Generation and Characterization of Site-Specifically Mono-Ubiquitylated p53. | Chembiochem | 2022 | 35025136 | PubTator, text mining | PubMed |
| Discovery of small-molecule positive allosteric modulators of Parkin E3 ligase. | iScience | 2022 | 35024585 | PubTator, text mining | PubMed |
| FBXW7-mediated ERK3 degradation regulates the proliferation of lung cancer cells. | Exp Mol Med | 2022 | 35022544 | PubTator, text mining | PubMed |
| Genetics of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS) and Role of Sacsin in Neurodegeneration. | Int J Mol Sci | 2022 | 35008978 | PubTator, text mining | PubMed |
| Modulation of Ubiquitin Signaling in Innate Immune Response by Herpesviruses. | Int J Mol Sci | 2022 | 35008917 | PubTator, text mining | PubMed |
| Reconstruction and Exploratory Analysis of mTORC1 Signaling Pathway and Its Applications to Various Diseases Using Network-Based Approach. | J Microbiol Biotechnol | 2022 | 35001007 | PubTator, text mining | PubMed |
| Nocardia rubra cell-wall skeleton influences the development of cervical carcinoma by promoting the antitumor effect of macrophages and dendritic cells. | Cancer Med | 2022 | 34994088 | PubTator, text mining | PubMed |
| Feasibility of Screening for Chromosome 15 Imprinting Disorders in 16 579 Newborns by Using a Novel Genomic Workflow. | JAMA Netw Open | 2022 | 34982160 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7337/papers?page=46